Fatemeh Rahimi Jamnani

Author

Also Known As

F R Jamnani, F Rahimi, F Rahimi Jamnani, F. R. Rahimi, F. Rahimi, Fatemeh Rahimi, Fatemeh Rahimi Jamnani, Fatemeh Rahimi-Jamnani, Fatemeh Rahimi‐Jamnani, Jamnani, Fatemeh Rahimi

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Pasteur Institute of Iran Biotechnology Research Center Tehran University of Medical Sciences Islamic Azad University, Science and Research Branch Tarbiat Modares University

About

Fatemeh Rahimi Jamnani is an author at Pasteur Institute of Iran specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	589
2	Engineering	3	3	51
3	Public Health	3	3	48
4	Health Sciences	1	1	23
5	Natural Sciences	1	1	16

Fatemeh Rahimi Jamnani

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Microbiota-Derived Extracellular Vesicles as New Systemic Regulators Sara Ahmadi Badi, Arfa Moshiri, Abolfazl Fateh, Frontiers in Microbiology	2017	125
Ulvan from green algae Ulva intestinalis: optimization of ultrasound-assisted extraction and antioxidant activity Fatemeh Rahimi Jamnani, Mehdi Tabarsa, Masoud Rezaei Journal of Applied Phycology PharmacologyUltrasound-assisted ExtractionAntioxidant ActivityDigestive Tract	2016	117
T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: Towards tumor-directed oligoclonal T cell therapy Fatemeh Rahimi Jamnani, Fatemeh Rahbarizadeh, Mohammad Ali Shokrgozar, Biochimica et Biophysica Acta (BBA) - General Subjects Cell TherapyTumor ImmunologyT CellsImmunologyAntigen Processing	2013	89
Comparative study of effect of <i>Akkermansia muciniphila</i> and its extracellular vesicles on toll-like receptors and tight junction. Fatemeh Ashrafian, Ava Behrouzi, Arefeh Shahriary, PubMed	2019	87
Genetically engineered T cells bearing chimeric nanoconstructed receptors harboring TAG-72-specific camelid single domain antibodies as targeting agents Zahra Sharifzadeh, Fatemeh Rahbarizadeh, Mohammad Ali Shokrgozar, Cancer Letters T CellsImmunoengineeringImmunologyAntigen ProcessingAutoimmunity	2012	74
High Prevalence of Bedaquiline Resistance in Treatment-Naive Tuberculosis Patients and Verapamil Effectiveness Hasan Ghajavand, Mansour Kargarpour Kamakoli, Sharareh Khanipour, Antimicrobial Agents and Chemotherapy Tuberculosis PreventionPathologyPharmacotherapyAntimicrobial ChemotherapyResistance Mutations	2019	63
Scrutinizing the drug resistance mechanism of multi- and extensively-drug resistant Mycobacterium tuberculosis: mutations versus efflux pumps Hasan Ghajavand, Mansour Kargarpour Kamakoli, Sharareh Khanipour, Antimicrobial Resistance and Infection Control	2019	57
Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells Fatemeh Rahimi Jamnani, Fatemeh Rahbarizadeh, Mohammad Ali Shokrgozar, Experimental Cell Research Tumor BiologyProtein NanoparticlesTumor TargetingEpitope-distinct Oligoclonal NanobodiesRadiation Oncology	2012	53
Evaluation of the impact of polyclonal infection and heteroresistance on treatment of tuberculosis patients Mansour Kargarpour Kamakoli, Hamid Reza Sadegh, Ghazaleh Farmanfarmaei, Scientific Reports	2017	48
Targeting long non-coding RNA MALAT1 reverses cancerous phenotypes of breast cancer cells through microRNA-561-3p/TOP2A axis Sara Hajibabaei, Nahid Nafissi, Yasamin Azimi, Scientific Reports	2023	36

Page 1